NSCLC - Non Small Cell Lung Cancer Now Closed
CCTG BR.31 - Hosted By elie
Save
Bookmark
Print
Sponsor Name | |
Tumor Site | NSCLC - Non Small Cell Lung Cancer |
Disease Stage | Stage I, Stage II, Stage III |
Clinical Status | Adjuvant, Operable |
Phase | Phase III |
Intervention / Treatment | Durvalumab versus Placebo |
Research Site | Quebec, Quebec Heart and Lung Institute |
Investigator | Dre Lise Tremblay |
Telephone Number | +1 418 656-8711 |
Study Start Date | October 9, 2014 |
Study End Date | January 1, 2023 |
Trial Status | Recruitment |